Analyzing liver lesions using advanced ultrasound imaging techniques
Research on Key Techniques for Intelligent Diagnosis and Ablation Decision-making of Liver Cancer and Evolution by Contrast-enhanced Ultrasound
This study is testing a new ultrasound technique to see if it can help doctors better identify and understand liver lesions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT04682886 on ClinicalTrials.gov |
What this trial studies
This study focuses on enhancing the diagnosis of focal liver lesions (FLLs) through contrast-enhanced ultrasound (CEUS) imaging. It aims to collect standard data from CEUS recordings and develop a deep learning model to improve the segmentation, detection, and classification of liver lesions. By leveraging digital information technology, the study seeks to address challenges such as interobserver variability and the dependence on clinician experience. The ultimate goal is to create an intelligent diagnostic system that can provide more accurate assessments of liver lesions.
Who should consider this trial
Good fit: Ideal candidates include patients with solid liver tumors that are visible during routine ultrasound and have undergone CEUS.
Not a fit: Patients with hypersensitivity to ultrasound contrast media, pregnant or lactating individuals, or those with previously treated lesions will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and reliable diagnoses of liver lesions, improving patient outcomes.
How similar studies have performed: While the use of CEUS for liver lesion diagnosis is established, the integration of deep learning for improved accuracy represents a novel approach that has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. patients with a solid liver tumor visible during routine ultrasound and received CEUS. 2. disease history and standard of reference of the lesions can be acquired Exclusion Criteria: 1. hypersensitivity for ultrasound contrast media 2. pregnant or lactating patients 3. previously treated lesions or local relapse from previously treated lesions 4. diffuse tumors
Where this trial is running
Beijing, Beijing
- Chinese PLA General Hospital — Beijing, Beijing, China (Recruiting)
Study contacts
- Study coordinator: Jie Yu, Dr
- Email: jiemi301@163.com
- Phone: 15901417963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.